Tag: Jean-Michel Boers
Exclusive: Boehringer Ingelheim USA President/CEO Jean-Michel Boers on firm’s 50th anniversary,...
“The speed at which the industry was able to offer highly efficacious vaccinations is quite extraordinary,” Boers marvels. “It shows how important it is to invest in health care in the U.S.”
Danbury Mayor Boughton named state DRS commissioner; Delivers farewell address
Mark Boughton, who is in the midst of his record 10th term as the city’s mayor, will begin his new job on Dec. 18.
Boehringer Ingelheim appoints Yew Looi Liew as U.S. Human Pharma president
Liew, who succeeds Jean-Michel Boers, will be responsible for developing BI’s current human pharma portfolio and preparing the organization for future launches.
Jean-Michel Boers succeeding Wolfgang Baiker as head of Boehringer Ingelheim U.S.
Boers joined Boehringer Ingelheim in 1998 in Belgium, and came to the U.S. in 2016 as senior vice president of the Specialty Care Franchise; he has led the U.S. Human Pharma business since January 2017.
